Posaconazole Oral Suspension
Last Updated: August 11, 2015
Products Affected - Description
Posaconazole oral suspension
Reason for the Shortage
- Merck states the shortage was due to manufacturing delays.
- Noxafil delayed-release tablets and intravenous injections are not affected by this shortage.
- Merck is the only supplier of posaconazole oral suspension.
Noxafil oral suspension, Merck
40 mg/mL, 105 mL glass bottle, 1 count (NDC 00085-1328-01)
Estimated Resupply Dates
All presentations are currently available.
- Fluconazole Injection — Resolved
August 11, June 8, April 20, March 2, January 28, 2015; December 22, 2014; November 26, 2014; November 6, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.